We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.00
Bid: 321.00
Ask: 323.00
Change: 1.00 (0.31%)
Spread: 2.00 (0.623%)
Open: 322.00
High: 322.00
Low: 322.00
Prev. Close: 321.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Project Helix

19 Mar 2019 15:16

RNS Number : 3441T
Bank of Cyprus Holdings PLC
19 March 2019
 

Announcement

 

Update on Project Helix - Agreement for the sale of a portfolio of non-performing loans

 

 

Nicosia, 19 March 2019

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014

 

 

Further to the announcement of 28 August 20181 in relation to the agreement for the sale of a portfolio of non-performing loans, known as "Project Helix", or the "Transaction", Bank of Cyprus Holdings Public Limited Company ("BOCH" and, together with its subsidiaries, the "Group") announces that it has received approval from the ECB for the Significant Risk Transfer ("SRT") benefit from the Transaction.

This is an important step towards completion of the Transaction, which remains subject to various outstanding conditions precedent1. Completion is currently expected to occur in early 2Q2019.

As previously reported, the Transaction reduces the Group's non-performing exposures (NPEs) by €2.7 bn and improves the NPE ratio from 47% to 36%3. The NPE provisioning coverage ratio pro forma for the Transaction stands at 47%3.

On completion, the derecognition of the Helix portfolio is expected to have a positive impact on the capital ratios of 160 basis points2, resulting from the release of risk weighted assets.

As at 31 December 2018, as previously reported, the Group's phased-in CET1 ratio and Total capital ratio, pro forma for both DTC2 and Helix, stood at 15.4% and 18.3% respectively.

For further information, please contact Investor Relations at investors@bankofcyprus.com.

[1] Further to the announcement of 28 August 2018 and updates provided with the publication of the Group financial results for the nine months ended 30 September 2018 and the preliminary Group financial results for the year ended 31 December 2018

2 Refer to slide 36 of the presentation for the preliminary Group financial results for the year ended 31 December 2018 published on 4 March 2019

3 Based on the preliminary Group financial results for the year ended 31 December 2018

4 DTC refers to the amendments in the legislation adopted by the Cyprus Parliament on 1 March 2019 and was published on the Official Gazette of the Republic on 15 March 2019

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 112 branches in Cyprus. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 4,146 staff worldwide. At 31 December 2018, the Group's Total Assets amounted to €22.1 bn and Total Equity was €2.4 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FURLLFLEVVIALIA
Date   Source Headline
9th Apr 202012:08 pmRNSSecond Price Monitoring Extn
9th Apr 202012:02 pmRNSPrice Monitoring Extension
8th Apr 202012:08 pmRNSSecond Price Monitoring Extn
8th Apr 202012:03 pmRNSPrice Monitoring Extension
6th Apr 20204:41 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
3rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
3rd Apr 202012:02 pmRNSPrice Monitoring Extension
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20204:41 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20204:40 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
27th Mar 202012:07 pmRNSSecond Price Monitoring Extn
27th Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20204:44 pmRNSSecond Price Monitoring Extn
20th Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 202010:25 amRNSAnnouncement
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
16th Mar 20206:05 pmRNSTrading Update
16th Mar 20205:55 pmRNSUpdate on Coronavirus & NPE Sale
16th Mar 20204:39 pmRNSPrice Monitoring Extension
13th Mar 20204:41 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
21st Jan 202010:23 amRNSTR-1 Notification-Morgan Stanley
20th Jan 20208:34 amRNSTR-1 Notification-Caius Capital
2nd Dec 20191:50 pmRNSEthics, Conduct and Culture Committee (ECCC)
29th Nov 20195:24 pmRNSEU-wide Transparency Exercise 2019
29th Nov 201910:58 amRNSDate of Annual General Meeting
26th Nov 201910:49 amRNSInvestor Presentation of BOCH 9M2019 - Replacement
26th Nov 20197:04 amRNSInvestor Presentation of BOCH 9M2019 FR
26th Nov 20197:02 amRNSBOCH Group Financial Results 9M2019
7th Nov 20197:57 amRNSTR-1 Notification -Caius Capital
6th Nov 201912:54 pmRNSNotice of Results
31st Oct 20198:03 amRNSCompletion of Voluntary Staff Exit Plan
7th Oct 201912:05 pmRNSCompletion of the sale of investment in CNP
3rd Sep 201912:44 pmRNSTR-1 Notification of Major Holding- Caius Capital
2nd Sep 20192:59 pmRNSDirectorate Change
27th Aug 20198:23 amRNSInterim Financial Report 2019
27th Aug 20197:07 amRNSAppointment of Chief Executive Officer
27th Aug 20197:05 amRNSChanges in Group organisational structure
27th Aug 20197:00 amRNS1H2019 Announcement for the Investor Presentation
27th Aug 20197:00 amRNSGroup Financial Results 6M2019
12th Aug 20198:02 amRNSNotice of Results 1H2019
5th Aug 20194:36 pmRNSPrice Monitoring Extension
8th Jul 201912:41 pmRNSTR-1 Notification of Major Holding-TD Asset Manag.
5th Jul 201912:31 pmRNSPDMR Notification of Transaction - Arapoglou
5th Jul 20199:59 amRNSTR-1 Notification of Major Holding-TD Asset Manag.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.